Cargando…
P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429573/ http://dx.doi.org/10.1097/01.HS9.0000968636.18625.e3 |
_version_ | 1785090748637511680 |
---|---|
author | Tettero, Jesse Palmieri, Raffaele Lam Ngai, Lok Bachas, Costa Arena, Valentina Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Maurillo, Luca Pabst, Thomas Passweg, Jakob Piciocchi, Alfonso Porkka, Kimmo Löwenberg, Bob Venditti, Adriano Ossenkoppele, Gert Buccisano, Francesco Cloos, Jacqueline |
author_facet | Tettero, Jesse Palmieri, Raffaele Lam Ngai, Lok Bachas, Costa Arena, Valentina Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Maurillo, Luca Pabst, Thomas Passweg, Jakob Piciocchi, Alfonso Porkka, Kimmo Löwenberg, Bob Venditti, Adriano Ossenkoppele, Gert Buccisano, Francesco Cloos, Jacqueline |
author_sort | Tettero, Jesse |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104295732023-08-17 P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL Tettero, Jesse Palmieri, Raffaele Lam Ngai, Lok Bachas, Costa Arena, Valentina Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Maurillo, Luca Pabst, Thomas Passweg, Jakob Piciocchi, Alfonso Porkka, Kimmo Löwenberg, Bob Venditti, Adriano Ossenkoppele, Gert Buccisano, Francesco Cloos, Jacqueline Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429573/ http://dx.doi.org/10.1097/01.HS9.0000968636.18625.e3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Tettero, Jesse Palmieri, Raffaele Lam Ngai, Lok Bachas, Costa Arena, Valentina Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Maurillo, Luca Pabst, Thomas Passweg, Jakob Piciocchi, Alfonso Porkka, Kimmo Löwenberg, Bob Venditti, Adriano Ossenkoppele, Gert Buccisano, Francesco Cloos, Jacqueline P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title | P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title_full | P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title_fullStr | P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title_full_unstemmed | P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title_short | P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL |
title_sort | p432: validation of limit of quantification approach based flow cytometry for measurable residual disease assessment in acute myeloid leukemia in the hovon-sakk-132 trial |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429573/ http://dx.doi.org/10.1097/01.HS9.0000968636.18625.e3 |
work_keys_str_mv | AT tetterojesse p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT palmieriraffaele p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT lamngailok p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT bachascosta p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT arenavalentina p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT breemsdimitri p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT fischerthomas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT toregjertsenbjorn p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT griskeviciuslaimonas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT juliussongunnar p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT maertensjohan p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT manzmarkus p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT maurilloluca p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT pabstthomas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT passwegjakob p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT piciocchialfonso p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT porkkakimmo p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT lowenbergbob p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT vendittiadriano p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT ossenkoppelegert p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT buccisanofrancesco p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial AT cloosjacqueline p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial |